Targeted SNP Genotyping Using the TaqMan® Assay

  • Dorit Schleinitz
  • Johanna K. DiStefano
  • Peter Kovacs
Part of the Methods in Molecular Biology book series (MIMB, volume 700)


More than 99% of genomic DNA sequence is identical among humans, and not surprisingly, slight variations in sequence can often produce a major effect on phenotype. Sequence variants may also mediate the manner in which humans are susceptible to disease or respond to environmental factors such as bacteria, viruses, toxins, chemicals, drugs, and therapeutic interventions. Single-nucleotide polymorphisms (SNPs) are DNA sequence variations that occur when a single base in the genome sequence can be represented by at least two different nucleotides. In the last decade, numerous SNPs have been identified that explain, at least partially, the genetic architecture of complex diseases such as cancer, diabetes, vascular complications, some forms of mental illness, and a multitude of other disorders. Disease-related SNPs are commonly identified through candidate gene approaches, or more recently, through genome-wide association studies. In either case, findings of association require verification in independent, population-based, study samples, usually consisting of several hundreds/thousands of individuals. A convenient technique to genotype a moderate number of markers in this kind of study is available with the TaqMan® platform (Applied Biosystems; Foster City, CA), which utilizes polymerase chain reaction amplification and allelic discrimination to easily and efficiently generate genotype data in a cost-effective way. Here, we introduce and describe this commonly used technique and include protocols that can be directly used in laboratories aiming to perform moderate- to large-scale genotyping studies.

Key words

SNP TaqMan® Genotype–phenotype association study PCR 


  1. 1.
    Cargill M, Altshuler D, Ireland J et al (1999) Characterisation of single-nucleotide polymorphisms in coding regions of human genes. Nat Genet 22:231–238PubMedCrossRefGoogle Scholar
  2. 2.
    Tindall EA, Speight G, Petersen DC, Padilla EJD, Hayes VM (2007) Novel Plexor™ SNP genotyping technology: comparisons with TaqMan® and homogenous MassEXTEND™ MALDI-TOF mass spectrometry. Hum Mutat 28(9):922–927PubMedCrossRefGoogle Scholar
  3. 3.
    The International HapMap Consortium (2003) International HapMap Project. Nature 426:789–796CrossRefGoogle Scholar
  4. 4.
    Kruglyak L, Nickerson DA (2001) Variation is the spice of life. Nat Genet 27:234–236PubMedCrossRefGoogle Scholar
  5. 5.
    Frayling TM, Timpson NJ, Weedon MN et al (2007) A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity. Science 316(5826):889–894PubMedCrossRefGoogle Scholar
  6. 6.
    Mergen M, Mergen H, Ozata M, Orner R, Orner C (2001) A novel melanocortin 4 receptor (MC4R) gene mutation associated with morbid obesity. J Clin Endocrinol Metab 86(7):3448PubMedCrossRefGoogle Scholar
  7. 7.
    Stefansson H, Ophoff RA, Steinberg S et al (2009) Common variants conferring risk of schizophrenia. Nature 460(7256):744–747PubMedGoogle Scholar
  8. 8.
    Eeles RA, Kote-Jarai Z, Giles GG et al (2008) Multiple newly identified loci associated with prostate cancer susceptibility. Nat Genet 40(3):316–21PubMedCrossRefGoogle Scholar
  9. 9.
    Stacey SN, Manolescu A, Sulem P et al (2007) Common variants on chromosomes 2q35 and 16q12 confer susceptibility to estrogen receptor-positive breast cancer. Nat Genet 39(7):865–869PubMedCrossRefGoogle Scholar
  10. 10.
    Becker KG (2004) The common variants/multiple disease hypothesis of common complex genetic disorders. Med Hypotheses 62(2):309–317PubMedCrossRefGoogle Scholar
  11. 11.
    Evans WE, McLeod HL (2003) Pharmacogenomics-drug disposition, drug targets, and side effects. N Engl J Med 348:538–549PubMedCrossRefGoogle Scholar
  12. 12.
    Livak KJ, Marmaro J, Todd JA (1995) Towards fully automated genome-wide polymorphism screening. Nat Genet 9:341–342PubMedCrossRefGoogle Scholar
  13. 13.
    Kutyavin IV, Afonina IA, Mills A et al (2000) 3′-Minor groove binder-DNA probes increase sequence specificity at PCR extension temperatures. Nucleic Acids Res 28(2):655–661PubMedCrossRefGoogle Scholar
  14. 14.
    Applied Biosystems (2010) TaqMan® SNP Genotyping Assays. Product Bulletin.

Copyright information

© Springer Science+Business Media, LLC 2011

Authors and Affiliations

  • Dorit Schleinitz
    • 1
  • Johanna K. DiStefano
    • 2
  • Peter Kovacs
    • 1
  1. 1.Interdisciplinary Center for Clinical ResearchUniversity of LeipzigLeipzigGermany
  2. 2.Diabetes, Cardiovascular, and Metabolic Diseases DivisionTranslational Genomics Research InstitutePhoenixUSA

Personalised recommendations